{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:45:20Z","timestamp":1792007120431,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["JCYJ20220818101405011"],"award-info":[{"award-number":["JCYJ20220818101405011"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023B1515020104"],"award-info":[{"award-number":["2023B1515020104"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171390"],"award-info":[{"award-number":["32171390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82261138630"],"award-info":[{"award-number":["82261138630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32201154"],"award-info":[{"award-number":["32201154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112069","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T06:00:05Z","timestamp":1713592805000},"page":"112069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["EGCG suppresses PD-1 expression of T cells via inhibiting NF-\u03baB phosphorylation and nuclear translocation"],"prefix":"10.1016","volume":"133","author":[{"given":"Zhong-Da","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhe","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7242-4687","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112069_b0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.immuni.2016.04.023","article-title":"Targeting T cell co-receptors for cancer therapy","volume":"44","author":"Callahan","year":"2016","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2024.112069_b0010","doi-asserted-by":"crossref","first-page":"eabd2712","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2024.112069_b0015","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112069_b0020","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112069_b0025","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112069_b0030","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112069_b0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/cas.16094","article-title":"Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: a real-world study (HOT2101)","volume":"115","author":"Tsuji","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2024.112069_b0040","doi-asserted-by":"crossref","first-page":"e1717","DOI":"10.1002\/wnan.1717","article-title":"The synergistic strategies for the immuno-oncotherapy with photothermal nanoagents","volume":"13","author":"Zhang","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2024.112069_b0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncr.31043","article-title":"Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: a systematic analysis of the literature","volume":"124","author":"Pillai","year":"2018","journal-title":"Cancer."},{"key":"10.1016\/j.intimp.2024.112069_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112069_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2011.10.001","article-title":"Green tea EGCG, T cells, and T cell-mediated autoimmune diseases","volume":"33","author":"Wu","year":"2012","journal-title":"Mol. Aspects. Med."},{"key":"10.1016\/j.intimp.2024.112069_b0060","doi-asserted-by":"crossref","first-page":"e1850","DOI":"10.1002\/wnan.1850","article-title":"The importance of the IL-1 family of cytokines in nanoimmunosafety and nanotoxicology","volume":"14","author":"Zhang","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2024.112069_b0065","first-page":"S145","article-title":"839 Dual targeting autoinflammation and PD-L1\/L2 immune checkpoint by EGCG augments anti-tumor effects in melanoma","volume":"139","author":"Li","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2024.112069_b0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jn\/134.5.1039","article-title":"Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells","volume":"134","author":"Wheeler","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.intimp.2024.112069_b0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bcp.2011.07.063","article-title":"EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells","volume":"82","author":"Hoffmann","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112069_b0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2012.03.039","article-title":"(-)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357","volume":"684","author":"H\u00e4rdtner","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112069_b0085","doi-asserted-by":"crossref","first-page":"e2302865","DOI":"10.1002\/adhm.202302865","article-title":"Strengthening the combinational immunotherapy from modulating the tumor inflammatory environment via hypoxia-responsive nanogels","volume":"13","author":"Luo","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.intimp.2024.112069_b0090","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1021\/acsanm.2c05472","article-title":"Tea polyphenol coordinated with nanoparticles of ZIF-8 and coated with polydopamine and PEG for immuno-oncotherapy","volume":"6","author":"Jannatun","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.intimp.2024.112069_b0095","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1021\/acsami.1c08201","article-title":"Reinforcing the combinational immuno-oncotherapy of switching \u201cCold\u201d tumor to \u201cHot\u201d by responsive penetrating nanogels","volume":"13","author":"Song","year":"2021","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"10.1016\/j.intimp.2024.112069_b0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","article-title":"FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells","volume":"564","author":"Meng","year":"2018","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2024.112069_b0105","doi-asserted-by":"crossref","first-page":"1020357","DOI":"10.1155\/2017\/1020357","article-title":"Mitochondrial ferritin deletion exacerbates \u03b2-amyloid-induced neurotoxicity in mice","volume":"2017","author":"Wang","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2024.112069_b0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/ars.2009.3018","article-title":"Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease","volume":"13","author":"Shi","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2024.112069_b0115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41419-022-05459-4","article-title":"The divergent effects of astrocyte ceruloplasmin on learning and memory function in young and old mice","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112069_b0120","first-page":"1025","article-title":"Caffeine decreases hepcidin expression to alleviate aberrant iron metabolism under inflammation by regulating the IL-6\/STAT3 pathway","volume":"12","author":"Li","year":"2022","journal-title":"Life (Basel)."},{"key":"10.1016\/j.intimp.2024.112069_b0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2014.09.071","article-title":"Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease","volume":"284","author":"You","year":"2015","journal-title":"Neuroscience."},{"key":"10.1016\/j.intimp.2024.112069_b0130","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s00018-020-03737-y","article-title":"Transcriptional and epigenetic regulation of PD-1 expression","volume":"78","author":"Chi","year":"2021","journal-title":"Cell. Mol. Life. Sci."},{"key":"10.1016\/j.intimp.2024.112069_b0135","doi-asserted-by":"crossref","first-page":"1331641","DOI":"10.3389\/fimmu.2024.1331641","article-title":"The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112069_b0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell."},{"key":"10.1016\/j.intimp.2024.112069_b0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","article-title":"The noncanonical NF-\u03baB pathway","volume":"246","author":"Sun","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112069_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ph14111081","article-title":"EGCG inhibits tumor growth in melanoma by targeting JAK-STAT signaling and its downstream PD-L1\/PD-L2-PD1 axis in tumors and enhancing cytotoxic T-cell responses","volume":"14","author":"Ravindran Menon","year":"2021","journal-title":"Pharmaceuticals (basel)"},{"key":"10.1016\/j.intimp.2024.112069_b0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.112069_b0160","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell."},{"key":"10.1016\/j.intimp.2024.112069_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701485","article-title":"Applications of magnetite nanoparticles in cancer immunotherapies: present hallmarks and future perspectives","volume":"12","author":"Song","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112069_b0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell."},{"key":"10.1016\/j.intimp.2024.112069_b0175","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.intimp.2024.112069_b0180","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1053\/j.gastro.2021.06.025","article-title":"Interferon-gamma-producing CD8+ tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor-colitis","volume":"161","author":"Sasson","year":"2021","journal-title":"Gastroenterology."},{"key":"10.1016\/j.intimp.2024.112069_b0185","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.06.001","article-title":"Molecular pathways of colon inflammation induced by cancer immunotherapy","volume":"182","author":"Luoma","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.intimp.2024.112069_b0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41591-021-01623-z","article-title":"T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma","volume":"28","author":"Lozano","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.112069_b0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12935-023-03161-9","article-title":"Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns","volume":"23","author":"Wang","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2024.112069_b0200","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","article-title":"NFATc1 regulates PD-1 expression upon T cell activation","volume":"181","author":"Oestreich","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112069_b0205","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.4049\/jimmunol.1402550","article-title":"NF-\u03baB regulates PD-1 expression in macrophages","volume":"194","author":"Bally","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112069_b0210","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","article-title":"The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection","volume":"41","author":"Staron","year":"2014","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2024.112069_b0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnut.2014.00028","article-title":"Enhancement of cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate","volume":"1","author":"Kilic","year":"2015","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2024.112069_b0220","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112069_b0225","doi-asserted-by":"crossref","first-page":"e1928","DOI":"10.1002\/wnan.1928","article-title":"Imaging and monitoring of granzyme B in the immune response","volume":"16","author":"Li","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2024.112069_b0230","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/0008-5472.CAN-16-3346","article-title":"Granzyme B PET imaging as a predictive biomarker of immunotherapy response","volume":"77","author":"Larimer","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2024.112069_b0235","doi-asserted-by":"crossref","first-page":"eabc2777","DOI":"10.1126\/sciadv.abc2777","article-title":"Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy","volume":"6","author":"Nguyen","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2024.112069_b0240","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112069_b0245","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.toxlet.2017.06.008","article-title":"Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements","volume":"277","author":"Dekant","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.intimp.2024.112069_b0250","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2024.112069_b0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.taap.2014.12.018","article-title":"Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway","volume":"283","author":"Wang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112069_b0260","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1158\/1078-0432.CCR-04-2549","article-title":"Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals","volume":"11","author":"Chow","year":"2005","journal-title":"Clin. Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T16:06:12Z","timestamp":1715616372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924005873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":52,"alternative-id":["S1567576924005873"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112069","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGCG suppresses PD-1 expression of T cells via inhibiting NF-\u03baB phosphorylation and nuclear translocation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112069"}}